Jul 13, 2020 / 03:00PM GMT
Jeremy Feffer - LifeSci Advisors, LLC - Investor Relations
Good morning and welcome to the CytoSorbents KOL call on the use of CytoSorb for antithrombotic drug removal. (Operator Instructions)
As a reminder, this conference is being recorded, and a replay will be made available on the CytoSorbents website following the event. As another reminder, the company may make forward-looking statements during this event and a copy of the safe harbor statements can be found in the presentation, which will also be made available on the CytoSorbents website.
At this time, I would like to turn the call over to Dr. Phillip Chan, CEO of CytoSorbents. Please go ahead, Phil.
Phillip P. Chan - Cytosorbents Corporation - CEO, President & Director
Thank you, Jeremy, and welcome, everyone, and thank you for joining today. We're very excited to bring together a distinguished panel of speakers with Drs. Gibson, Storey and Schmoeckel to discuss CytoSorb removal of antithrombotic agents. Before handing it over to our Chief Medical Officer and host for today, Dr.
Cytosorbents Corporation - Special Call Transcript
Jul 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers